The current financial score of Adicet Bio Inc is 6.43. Its financial status is weak, and its operating efficiency is high.
The current valuation score of Adicet Bio Inc is 8.04. Its current P/E ratio is -0.61, which is -47.79% below the recent high of -0.32 and -1043.92% above the recent low of -7.00.
The current earnings forecast score of Adicet Bio Inc is 9.00. The average price target is 33.17, with a high of 90.00 and a low of 18.00.
The current price momentum score of Adicet Bio Inc is 4.16. Currently, the stock price is trading between the resistance level at 9.67 and the support level at 7.61, making it suitable for range-bound swing trading.
The current institutional shareholding score of Adicet Bio Inc is 7.00. The latest institutional shareholding proportion is 75.97%, representing a quarter-over-quarter increase of 66.85%. The largest institutional shareholder is James Simons, holding a total of 265.94K shares, representing 0.00% of shares outstanding, with 241.68% increase in holdings.
The current risk assessment score of Adicet Bio Inc is 2.72. The company's beta value is 1.53. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.